Table 1.
Patient and treatment characteristics
| Characteristic | n = 41 (%) |
|---|---|
| Age at diagnosis | |
| Median | 71 |
| Range | 45-89 |
| Sex | |
| Male | 22 (54) |
| Female | 19 (46) |
| Tumor location | |
| Intrahepatic | 26 (63) |
| Perihilar | 15 (37) |
| Tumor size (cm) | |
| Median | 4.2 |
| Range | 1.0-12.5 |
| Lymph node status | |
| Positive | 6 (15) |
| Negative | 35 (85) |
| ECOG performance status | |
| 1 | 26 (63) |
| 2 | 15 (37) |
| Child-Pugh class | |
| A | 23 (56) |
| B | 9 (22) |
| C | 2 (5) |
| Not assessable | 7 (17) |
| Prior chemotherapy | |
| Yes | 10 (24) |
| No | 31 (76) |
| Unknown | 0 (0) |
| Type of prior chemotherapy (n = 10) | |
| 5-FU | 1 (10) |
| Cisplatin | 6 (60) |
| Gemcitabine | 10 (100) |
| Adjuvant chemotherapy | |
| Yes | 17 (41) |
| No | 21 (51) |
| Unknown | 3 (8) |
| Radiation dose to primary tumor (Gy) | |
| Median | 40 |
| Range | 26-50 |
Abbreviation: 5-FU = 5-fluorouracil.